Objection pursuant to Rule 112 (2) and (3) to an implementing act granting marketing authorisation for "Paxlovid - Nirmatrelvir / ritonavir", a medicinal product for human use | GovLens
Objection pursuant to Rule 112 (2) and (3) to an implementing act granting marketing authorisation for "Paxlovid - Nirmatrelvir / ritonavir", a medicinal product for human use
